Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T70692 |
ST7612AA1
|
HIV Protease | Microbiology/Virology; Proteases/Proteasome |
ST7612AA1 是一种新型有效且可口服的 HDAC 抑制剂,作为作为HIV-1潜伏期再激活剂。ST7612AA1 在体内外实验中低浓度显示出显著的抗肿瘤活性。ST7612AA1 具有潜在的抗癌活性,可用于研究疟疾。 | |||
T18720 |
FCHFHS-ST7612AA1
|
Others | Others |
FCHFHS-ST7612AA1 is a part of antibody drug conjugates (ADCs) charged with HDAC inhibitor by a linker, shows antitumor activity[1]. | |||
T18721 |
MAC-VC-PABC-ST7612AA1
|
Others | Others |
MAC-VC-PABC-ST7612AA1 is a part of antibody drug conjugates (ADCs) charged with HDAC inhibitor by a linker, shows antitumor activity[1]. | |||
T70690 |
UAWJ246
|
||
UAWJ246 is a SARS-CoV-2 Protease inhibitor (IC50 = 45 nM). UAWJ246 provides new directions for the development of Mpro inhibitors as SARS-CoV-2 antivirals. |